| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ASTH | Common Stock | Award | $0 | +15.7K | +9.99% | $0.00 | 173K | Apr 2, 2024 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | Represents a grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares shall vest in eight equal semi-annual installments beginning on October 2, 2024 (the six month anniversary of the grant date). |
| F2 | Includes 152,372 shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 21,640 shares, which vest in three equal annual installments on April 14, 2024, 2025, and 2026; (ii) 9,121 shares, which vest in two equal annual installments on May 16, 2024 and 2025; (iii) 60,808 shares, which vest in four equal annual installments on May 16, 2024, 2025, 2026 and 2027; and (iv) 60,803 shares, which vest upon achievement of certain pre-established performance goals. Also includes 15,692 restricted stock units, which will vest in eight equal semi-annual installments beginning on October 2, 2024 (subject to continuous employment with the Issuer). |
Effective February 26, 2024, the Issuer changed its legal name from Apollo Medical Holdings, Inc. to Astrana Health, Inc.